DarioHealth Corp. (DRIO)
- Previous Close
0.7197 - Open
0.7489 - Bid 0.6761 x 100
- Ask 0.7659 x 100
- Day's Range
0.7111 - 0.7500 - 52 Week Range
0.5010 - 1.9300 - Volume
45,053 - Avg. Volume
375,129 - Market Cap (intraday)
29.725M - Beta (5Y Monthly) 1.56
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6100 - Earnings Date May 13, 2025 - May 19, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
2.33
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
www.dariohealth.com196
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: DRIO
View MorePerformance Overview: DRIO
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DRIO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DRIO
View MoreValuation Measures
Market Cap
29.92M
Enterprise Value
31.65M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.31
Price/Book (mrq)
0.42
Enterprise Value/Revenue
1.17
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-158.09%
Return on Assets (ttm)
-33.11%
Return on Equity (ttm)
-65.68%
Revenue (ttm)
27.04M
Net Income Avi to Common (ttm)
-30.09M
Diluted EPS (ttm)
-0.6100
Balance Sheet and Cash Flow
Total Cash (mrq)
28.46M
Total Debt/Equity (mrq)
41.92%
Levered Free Cash Flow (ttm)
-11.83M